Pramipexole is a medicine used to treat Parkinson's disease and restless legs syndrome. It works by helping the brain use dopamine, a chemical that helps control movement. It's taken as a pill, usually once a day.
Every report comes from a Lived member, sent anonymously.
Have you tried Mirapex (Pramipexole) for Restless Legs Syndrome?
Pramipexole is a prescription medicine for Parkinson's disease and for moderate to severe restless legs syndrome (RLS), a condition that causes an uncomfortable urge to move the legs, usually in the evening or at night. It belongs to a group called dopamine agonists. The original brand, Mirapex, was an immediate-release tablet that is no longer sold in the US, though generic immediate-release pramipexole is widely available. An extended-release version, Mirapex ER (also available as a generic), is approved for Parkinson's disease only, not for RLS. In Parkinson's disease, pramipexole can be used on its own in the early stages or added to levodopa later on, when levodopa alone no longer controls symptoms smoothly. Levodopa is usually somewhat more effective at improving movement, and in a large British trial people who started on a dopamine agonist were far more likely to stop it because of side effects. For RLS, pramipexole often brings quick relief, but current US sleep medicine guidance no longer recommends it as a standard first choice, because symptoms can worsen with long-term use. Gabapentin-type medicines and, when iron levels are low, iron treatment are now usually preferred.
Dopamine is a chemical messenger the brain uses to coordinate smooth, deliberate movement. In Parkinson's disease, the nerve cells that make dopamine gradually die, which leads to slowness, stiffness and tremor. Pramipexole is not dopamine, but it attaches to the same receptors in the brain's movement centers and switches them on, partly standing in for the missing signal. Why it helps restless legs is less clear. RLS appears to involve a mild disturbance in dopamine signaling, and boosting that signal at night calms the urge to move for many people, but the exact mechanism is not known.
Pramipexole is started at a low dose and raised in small steps, usually no more often than every five to seven days, to find the lowest dose that works with tolerable side effects. The doses differ greatly by condition. For Parkinson's disease, immediate-release tablets are taken three times a day, while extended-release tablets are taken once a day and must be swallowed whole, never chewed, crushed or split. For RLS, a much smaller dose of the immediate-release tablet is taken once a day, two to three hours before bedtime. Never take immediate-release and extended-release pramipexole at the same time. Tablets can be taken with or without food, and taking them with food can ease nausea. Because the kidneys clear pramipexole, people with reduced kidney function usually need lower doses or slower increases. If someone already takes levodopa, the prescriber may lower the levodopa dose when pramipexole is added. Do not stop pramipexole suddenly or cut the dose sharply on your own. The dose is normally reduced gradually, because abrupt stopping can bring on a reaction with high fever, muscle stiffness and confusion, as well as withdrawal symptoms described below. Anyone who develops fever, rigid muscles or confusion after a dose cut or stopping should contact their prescriber right away.
Nausea, dizziness, sleepiness, trouble sleeping, constipation and weakness are common, especially in Parkinson's disease, where doses are higher. People taking it for RLS most often notice nausea, sleepiness, tiredness and headache. Dizziness or lightheadedness when standing up is most likely while the dose is being increased, so it helps to get up slowly. In people also taking levodopa, pramipexole can cause or worsen dyskinesia, which means involuntary twisting or jerking movements. Pramipexole can cause people to fall asleep suddenly during everyday activities such as eating, talking or driving, sometimes without feeling drowsy first, and this has led to car accidents. It can happen even a year after starting. Avoid driving until you know how the medicine affects you, and if you notice new daytime sleepiness or any episode of falling asleep, stop driving and contact your prescriber. Some people develop strong urges they find hard to control, such as gambling, shopping or spending, binge eating or increased sexual urges. People often do not recognize these changes in themselves, so it helps to tell family members to watch for them. They often ease when the dose is lowered or the medicine is stopped, so report them early. Hallucinations, confusion or unusual beliefs can occur, particularly in people with Parkinson's disease who are over 65. These should be reported to the prescriber.
Medicines that block dopamine can weaken pramipexole and may also worsen Parkinson's symptoms. These include many antipsychotic medicines and metoclopramide, a medicine for acid reflux and slow stomach emptying. Alcohol and other sedating medicines add to the sleepiness pramipexole causes. Cimetidine, a heartburn medicine, can raise pramipexole levels. People with a major psychotic disorder generally should not take a dopamine agonist, because it can worsen psychosis. For RLS, the main long-term concern is augmentation: over months or years, symptoms start earlier in the day, become stronger or spread to the arms. In the main trial it became more common the longer people took the medicine, and it is a reason to review treatment with the prescriber rather than simply take more. Stopping can also bring a temporary rebound of symptoms. Pramipexole lowers prolactin, a hormone needed for milk production, so it is expected to reduce breast milk supply. There is little information about its use in pregnancy, so anyone pregnant, planning pregnancy or breastfeeding should discuss it with their prescriber.
For RLS, the starting dose is often enough, and if not, it can be raised every four to seven days. In Parkinson's disease, reaching a helpful dose takes a few weeks of gradual increases, and improvement in stiffness, slowness and tremor builds over that time. Follow-up visits check how well symptoms are controlled and look specifically for daytime sleepiness, impulse control problems, hallucinations and, in RLS, early signs of augmentation, since people may not raise these themselves. A rarely reported problem in Parkinson's disease is a bending posture of the neck or trunk that develops months after starting or raising the dose and may improve when the dose is reduced. If pramipexole is stopped after long use, the dose is lowered gradually under supervision. Some people still develop withdrawal symptoms, such as apathy, anxiety, low mood, fatigue, poor sleep, sweating or pain, which do not respond to levodopa. These are worth reporting, because the prescriber may slow the taper or briefly restart a low dose.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Mirapex (Pramipexole), what you've noticed, or ask the community a question.